Safety profiles for once-weekly Ozempic (semaglutide) injection and once-daily Ozempic pill (semaglutide) injection and once-daily Ozempic pill Safety and tolerability evaluated across clinical trials Rates of GI symptoms across placebo-controlled trials with Ozempic injection and semaglutide tablets 1,2,a The most common adverse reactions reported in 5% of patients taking Ozempic injection and Ozempic tablets are nausea, vomiting, diarrhea, abdominal pain, and constipation
When reconstituting, bacteriostatic saline (not the plain saline it comes with) should be used to maintain sterility
Use appropriate needle length for subcutaneous injection, typically 27 to 31 gauge and half inch in length
Under no circumstances are these products approved or intended for human or veterinary consumption, diagnostic protocols, or therapeutic drug use
GLP-1 medications reduce appetite and slow gastric emptying, creating a prolonged feeling of fullness and leading to fewer calories consumed throughout the day
To lower the risk of Ozempic sulfur burps and other GI side effects, healthcare providers typically start with a low dose of Ozempic and gradually increase the dosage over time